· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Лечебное дело 2023 / N 3 Бессимптомная гиперурикемия как фактор риска при сердечно-сосудистых заболеваниях: лечить или не лечить? В.В. Шабалин, Н.С. Самсонов, Ю.И. Гринштейн Список литературы/References 1. Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. Journal of Cardiology. 2021;78(1):51-57. DOI: 10.1016/j.jjcc.2020.12.013 2. Freilich M, Arredondo A, Zonnoor SL, McFarlane IM. Elevated serum uric acid and cardiovascular disease: a review and potential therapeutic interventions. Cureus. 2022;14(3):e23582. DOI: 10.7759/cureus.23582 3. Cicero AFG, Fogacci F, Di Micoli V, Angeloni C, Giovannini M, Borghi C. Purine metabolism dysfunctions: experimental methods of detection and diagnostic potential. International Journal of Molecular Sciences. 2023;24(8):7027. DOI: 10.3390/ijms24087027 4. Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Annals of Rheumatic Diseases. 2018;77(7):1048-1052. DOI: 10.1136/annrheumdis-2017-212288 5. Ko YL. Genetics of hyperuricemia and gout: insights from recent genome-wide association studies and Mendelian randomization studies. Tzu Chi Medical Journal. 2022;34(3):261-269. DOI: 10.4103/tcmj.tcmj_117_21 6. Nian YL, You CG. Susceptibility genes of hyperuricemia and gout. Hereditas. 2022;159(1):30. DOI: 10.1186/s41065-022-00243-y 7. Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Annals of the Rheumatic Diseases. 2019;78(11):1592-1600. DOI: 10.1136/annrheumdis-2019-215933 8. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, Bae SS, Danve A, Khanna PP, Kim SC, Lenert A, Poon S, Qasim A, Sehra ST, Sharma TSK, Toprover M, Turgunbaev M, Zeng L, Zhang MA, Turner AS, Neogi T. 2020 American College of Rheumatology guideline for the management of gout. Arthritis & Rheumatology (Hoboken, N.J.). 2020;72(6):879-895. DOI: 10.1002/art.41247 9. Valsaraj R, Singh AK, Gangopadhyay KK, Ghoshdastidar B, Goyal G, Batin M, Mukherjee D, Sengupta U, Chatterjee S, Sengupta N. Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement. Diabetes & Metabolic Syndrome. 2020;14(2):93-100. DOI: 10.1016/j.dsx.2020.01.007 10. Hisatome I, Li P, Miake J, Taufiq F, Mahati E, Maharani N, Utami SB, Kuwabara M, Bahrudin U, Ninomiya H. Uric acid as a risk factor for chronic kidney disease and cardiovascular disease Japanese guideline on the management of asymptomatic hyperuricemia. Circulation Journal. 2021;85(2):130-138. DOI: 10.1253/circj.CJ-20-0406 11. Чазова И.Е., Жернакова Ю.В., Кисляк О.А., Подзолков В.И., Ощепкова Е.В., Миронова О.Ю., Блинова Н.В. Консенсус по ведению пациентов с гиперурикемией и высоким сердечно-сосудистым риском: 2022. Системные гипертензии. 2022;19(1):5-22. [Chazova IE, Zhernakova YuV, Kislyak OA, Podzolkov VI, Oshchepkova EV, Mironova OYu, Blinova NV. Consensus on patients with hyperuricemia and high cardiovascular risk treatment: 2022. Systemic Hypertension. 2022;19(1):5-22. (In Russ.).] DOI: 10.38109/2075-082X-2022-1-5-22 12. Драпкина О.М., Мазуров В.И., Мартынов А.И., Гайдукова И.З., Дупляков Д.В., Невзорова В.А., Остроумова О.Д., Чесникова А.И. “В фокусе гиперурикемия”. Резолюция Cовета экспертов. Кардиоваскулярная терапия и профилактика. 2023;22(4):3564. [Drapkina OM, Mazurov VI, Martynov AI, Gaidukova IZ, Duplyakov DV, Nevzorova VA, Ostroumova OD, Chesnikova AI. “Focus on hyperuricemia”. The resolution of the Expert Council. Cardiovascular Therapy and Prevention. 2023;22(4):3564. (In Russ.).] DOI:10.15829/1728-8800-2023-3564 13. Borghi C, Domienik-Karlowicz J, Tykarski A, Widecka K, Filipiak KG, Jaguszewski MJ, Narkiewicz K, Mancia G. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. Cardiology Journal. 2021;28(1):1-14. DOI: 10.5603/CJ.a2021.0001 14. Шальнова С.А., Деев А.Д., Артамонова Г.В., Дупляков Д.В., Ефанов А.Ю., Жернакова Ю.В., Конради А.О, Либис Р.А., Муромцева Г.А., Недогода С.В., Ощепкова Е.В., Романчук С.В., Ротарь О.П., Титов В.Н., Тогузова З.А., Трубачева И.А., Фурменко Г.И., Шляхто Е.В., Бойцов С.А., Баланова Ю.А., Евстифеева С.Е., Капустина А.В., Константинов В.В., Мамедов М.Н., Метельская В.А., Ледяева А.А., Чумачек Е.В., Минаков Э.В., Бабенко Н.И., Азарин О.Г., Бондарцов Л.В., Хвостикова А.Е., Белова О.А., Корулина Л.В., Назарова О.А., Шутемова Е.А., Скрипченко А.Е., Индукаева Е.В., Черкасс Н.В., Максимов С.А., Данильченко Я.В., Мулерова Т.А., Гудкова С.А., Черепанова Н.А., Исаева Е.Н., Лопина Е.А., Басырова И.Р., Кондратенко В.Ю., Сафонова Д.В., Кавешников В.С., Карпов Р.С., Серебрякова В.Н., Медведева И.В., Сторожок М.А., Шава В.П., Шалаев С.В., Гутнова С.К., Толпаров Г.В. Гиперурикемия и ее корреляты в российской популяции (результаты эпидемиологического исследования ЭССЕ-РФ). Рациональная фармакотерапия в кардиологии. 2014;10(2):153-159. [Shalnova SA, Deyev AD, Artamonova GV, Duplyakov DV, Yefanov AYu, Zhernakova YuV, Konradi AO, Libis RA, Muromtseva GA, Nedogoda SV, Oshchepkova EV, Romanchuk SV, Rotar OP, Titov VN, Toguzova ZA, Trubacheva IA, Furmenko GI, Shlyakhto EV, Boytsov SA, Balanova YuA, Yevstifeyeva SE, Kapustina AV, Konstantinov VV, Mamedov MN, Metelskaya VA, Ledyaeva A, Chumachek EV, Minakov EV, Babenko NI, Azarin OG, Bondartsov LV, Khvostikova AE, Belova OA, Korulina LV, Nazarova OA, Shutemova EA, Skripchenko AE, Indukayeva EV, Cherkass NV, Maksimov SA, Danilchenko YaV, Mulerova TA, Gudkova SA, Cherepanova NA, Isayeva EN, Lopina EA, Basyrova IR, Kondratenko VYu, Safonova DV, Kaveshnikov VS, Karpov RS, Serebryakova VN, Medvedeva IV, Storozhok MA, Shava VP, Shalayev SV, Gutnova SK, Tolparov GV. Hyperuricemia and its correlates in the Russian population (results of ESSE-RF epidemiological study). Rational Pharmacotherapy in Cardiology. 2014;10(2):153-159. (In Russ.).] DOI: 10.20996/1819-6446-2014-10-2-153-159 15. Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey, 2007–2016. Arthritis & Rheumatology (Hoboken, N.J.). 2019;71(6):991-999. DOI: 10.1002/art.40807 16. Li Y, Shen Z, Zhu B, Zhang H, Zhang X, Ding X. Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis. Global Health Action. 2021;14(1):1874652. DOI: 10.1080/16549716.2021.1874652 17. Antelo-Pais P, Prieto-Díaz MÁ, Micó-Pérez RM, Pallarés-Carratalá V, Velilla-Zancada S, Polo-García J, Barquilla-García A, Ginel-Mendoza L, Segura-Fragoso A, Vitelli-Storelli F, Martín-Sánchez V, Hermida-Ameijerias Á, Cinza-Sanjurjo S; Investigators of the IBERICAN Study and of the Spanish Society of Primary Care Physicians (SEMERGEN) Foundation. Prevalence of hyperuricemia and its association with cardiovascular risk factors and subclinical target organ damage. Journal of Clinical Medicine. 2022;12(1):50. DOI: 10.3390/jcm12010050 18. Higa S, Yoshida M, Shima D, Ii Y, Kitazaki S, Yamamoto Y, Fujimoto Y. A retrospective, cross-sectional study on the prevalence of hyperuricemia using a Japanese healthcare database. Archives of Rheumatology. 2019;35(1):41-51. DOI: 10.5606/ArchRheumatol.2020.7330 19. Butler F, Alghubayshi A, Roman Y. The epidemiology and genetics of hyperuricemia and gout across major racial groups: a literature review and population genetics secondary database analysis. Journal of Personalized Medicine. 2021;11(3):231. DOI: 10.3390/jpm11030231 20. Yokose C, McCormick N, Lu N, Tanikella S, Lin K, Joshi AD, Raffield LM, Warner E, Merriman T, Hsu J, Saag K, Zhang Y, Choi HK. Trends in prevalence of gout among US Asian adults, 2011–2018. JAMA Network Open. 2023;6(4):e239501. DOI: 10.1001/jamanetworkopen.2023.9501 21. Гринштейн Ю.И., Шабалин В.В., Руф Р.Р., Петрова М.М., Артюхов И.П., Шальнова С.А. Взаимосвязь гиперурикемии, функции почек и артериальной гипертонии у населения крупного региона Восточной Сибири. Российский кардиологический журнал. 2017;6:86-91. [Grinstein YuI, Shabalin VV, Ruf RR, Petrova MM, Artyukhov IP, Shalnova SA. Relation of hyperuricaemia, renal function and arterial hypertension in a large region of the Eastern Siberia inhabitants. Russian Journal of Cardiology. 2017;6:86-91. (In Russ.).] DOI: 10.15829/1560-4071-2017-6-86-91 22. Raya-Cano E, Vaquero-Abellán M, Molina-Luque R, De Pedro-Jiménez D, Molina-Recio G, Romero-Saldaña M. Association between metabolic syndrome and uric acid: a systematic review and meta-analysis. Science Reports. 2022;12(1):18412. DOI: 10.1038/s41598-022-22025-2 23. Nie G, Wan JJ, Jiang L, Hou SK, Peng W. Correlation analysis between uric acid and metabolic syndrome in the Chinese elderly population: a cross-sectional study. International Journal of Endocrinology. 2023;2023:8080578. DOI: 10.1155/2023/8080578 24. Wang H, Yao J, Ding N, He Y. Correlation of uric acid with body mass index based on NHANES 2013-2018 data: a cross-sectional study. Medicine (Baltimore). 2022;101(39):e30646. DOI: 10.1097/MD.0000000000030646 25. Alqahtani SAM, Awan ZA, Alasmary MY, Al Amoudi AM. Association between serum uric acid with diabetes and other biochemical markers. Journal of Family Medicine and Primary Care. 2022;11(4):1401-1409. DOI: 10.4103/jfmpc.jfmpc_1833_21 26. Gao Z, Shi H, Xu W, Guan Z, Su X, Guo N, Ma H. Hyperuricemia increases the risk of atrial fibrillation: a systematic review and meta-analysis. International Journal of Endocrinology. 2022;2022:8172639. DOI: 10.1155/2022/8172639 27. Tikhonoff V, Casiglia E, Spinella P, Barbagallo CM, Bombelli M, Cicero AFG, Cirillo M, Cirillo P, Desideri G, Delia L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Mallamaci F, Maloberti A, Masi S, Mazza A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Rivasi G, Salvetti M, Tocci G, Ungar A, Verdecchia P, Viazzi F, Virdis A, Volpe M, Grassi G, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA). Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study. Journal of Human Hypertension. 2022;36(11):976-982. DOI: 10.1038/s41371-021-00613-5 28. Gonçalves DLN, Moreira TR, da Silva LS. A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease. Scientific Reports. 2022;12(1):6251. DOI: 10.1038/s41598-022-10118-x 29. Rahimi-Sakak F, Maroofi M, Rahmani J, Bellissimo N, Hekmatdoost A. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. BMC. Cardiovascular Disorders. 2019;19(1):218. DOI: 10.1186/s12872-019-1215-z 30. Tian X, Wang A, Zuo Y, Chen S, Ma Y, Han X, Zhang L, Wu S, Luo Y. Changes in serum uric acid and the risk of cardiovascular disease and all-cause mortality in the general population. Nutrition, Metabolism and Cardiovascular Diseases. 2021;31(5):1401-1409. DOI: 10.1016/j.numecd.2020.12.034 31. Colantonio LD, Reynolds RJ, Merriman TR, Gaffo A, Singh JA, Plante TB, Chaudhary NS, Armstrong ND, Soliman EZ, Curtis JR, Bridges SL Jr, Lang L, Howard G, Safford MM, Saag KG, Muntner P, Irvin MR. Higher serum urate levels are associated with an increased risk for sudden cardiac death. The Journal of Rheumatology. 2021;48(11):1745-1753. DOI: 10.3899/jrheum.210139 32. Maloberti A, Biolcati M, Ruzzenenti G, Giani V, Leidi F, Monticelli M, Algeri M, Scarpellini S, Nava S, Soriano F, Oreglia J, Sacco A, Morici N, Oliva F, Piani F, Borghi C, Giannattasio C. The role of uric acid in acute and chronic coronary syndromes. Journal of Clinical Medicine. 2021;10(20):4750. DOI: 10.3390/jcm10204750 33. Kawamoto R, Kikuchi A, Ninomiya D, Kumagi T. Change in serum uric acid is a useful predictor of all-cause mortality among community-dwelling persons. International Journal of Analytical Chemistry. 2023;2023:7382320. DOI: 10.1155/2023/7382320 34. Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment. International Journal of Molecular Sciences. 2022;23(6):3188. DOI: 10.3390/ijms23063188 35. Yokose C, McCormick N, Choi HK. The role of diet in hyperuricemia and gout. Current Opinion in Rheumatology. 2021;33(2):135-144. DOI: 10.1097/BOR.0000000000000779 36. Topless RKG, Major TJ, Florez JC, Hirschhorn JN, Cadzow M, Dalbeth N, Stamp LK, Wilcox PL, Reynolds RJ, Cole JB, Merriman TR. The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect. Arthritis Research & Therapy. 2021;23(1):75. DOI: 10.1186/s13075-021-02444-8 37. Yi K, Cui S, Tang M, Wu Y, Xiang Y, Yu Y, Tong X, Jiang Y, Zhao Q, Zhao G. Adherence to DASH dietary pattern and its association with incident hyperuricemia risk: a prospective study in Chinese community residents. Nutrients. 2022;14(22):4853. DOI: 10.3390/nu14224853 38. Sautner J, Eichbauer-Sturm G, Gruber J, Lunzer R, Puchner RJ. 2022 update of the Austrian Society of Rheumatology and Rehabilitation nutrition and lifestyle recommendations for patients with gout and hyperuricemia. Wien Klinische Wochenschrift. 2022;134(13-14):546-554. DOI: 10.1007/s00508-022-02054-7 39. Zhu Q, Yu L, Li Y, Man Q, Jia S, Liu B, Zong W, Zhou Y, Zuo H, Zhang J. Association between dietary approaches to stop hypertension (DASH) diet and hyperuricemia among Chinese adults: findings from a nationwide representative study. Nutrition Journal. 2023;22(1):21. DOI: 10.1186/s12937-023-00845-w 40. Ayoub-Charette S, Chiavaroli L, Liu Q, Khan TA, Zurbau A, Au-Yeung F, Cheung A, Ahmed A, Lee D, Choo VL, Blanco Mejia S, de Souza RJ, Wolever TM, Leiter LA, Kendall CW, Jenkins DJ, Sievenpiper JL. Different food sources of fructose-containing sugars and fasting blood uric acid levels: a systematic review and meta-analysis of controlled feeding trials. The Journal of Nutrition. 2021;151(8):2409-2421. DOI: 10.1093/jn/nxab144 41. Leung N, Yip K, Pillinger MH, Toprover M. Lowering and raising serum urate levels: off-label effects of commonly used medications. Mayo Clinic Proceedings. 2022;97(7):1345-1362. DOI: 10.1016/j.mayocp.2022.02.027 42. Akbari A, Razmi M, Rafiee M, Watts GF, Sahebkar A. The effect of statin therapy on serum uric acid levels: a systematic review and meta-analysis. Current Medicinal Chemistry. 2023 Feb 7. DOI: 10.2174/0929867330666230207124516. Online ahead of print. 43. Akbari A, Rafiee M, Sathyapalan T, Sahebkar A. Impacts of sodium/glucose cotransporter-2 inhibitors on circulating uric acid concentrations: a systematic review and meta-analysis. Journal of Diabetes Research. 2022;2022:7520632. DOI: 10.1155/2022/7520632 44. Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, Jenkins W, Jordan KM, Mallen CD, McDonald TM, Nuki G, Pywell A, Zhang W, Roddy E; British Society for Rheumatology Standards, Audit and Guidelines Working Group. The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford, England). 2017;56(7):1246. DOI:10.1093/rheumatology/kex250 45. Lorenzo JPP, Sollano MHMZ, Salido EO, Li-Yu J, Tankeh-Torres SA, Wulansari Manuaba IAR, Rahman MM, Paul BJ, Mok MY, De Silva M, Padhan P, Lim AL, Marcial M, Vicera JJ, Haq SA, Salman S, Liyanage CK, Keen HI, Yew Kuang C, Wei JC, Hellmi RY, Chan CE Jr, Louthrenoo W. 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. International Journal of Rheumatic Diseases. 2022;25(1):7-20. DOI: 10.1111/1756-185X.14266 46. van der Pol KH, Wever KE, Verbakel M, Visseren FLJ, Cornel JH, Rongen GA. Allopurinol to reduce cardiovascular morbidity and mortality: a systematic review and meta-analysis. PLoS One. 2021;16(12):e0260844. DOI: 10.1371/journal.pone.0260844 47. Hu AM, Brown JN. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review. Clinical Rheumatology. 2020;39(11):3287-3294. DOI: 10.1007/s10067-020-05079-3 48. Ying H, Yuan H, Tang X, Guo W, Jiang R, Jiang C. Impact of serum uric acid lowering and contemporary uric acid-lowering therapies on cardiovascular outcomes: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2021;8:641062. DOI: 10.3389/fcvm.2021.641062 49. Sapankaew T, Thadanipon K, Ruenroengbun N, Chaiyakittisopon K, Ingsathit A, Numthavaj P, Chaiyakunapruk N, McKay G, Attia J, Thakkinstian A. Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials. BMC Nephrology. 2022;23(1):223. DOI: 10.1186/s12882-022-02850-3 50. Li X, Meng X, He Y, Spiliopoulou A, Timofeeva M, Wei WQ, Gifford A, Yang T, Varley T, Tzoulaki I, Joshi P, Denny JC, Mckeigue P, Campbell H, Theodoratou E. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide mendelian randomization study. PLoS Medicine. 2019;16(10):e1002937. DOI: 10.1371/journal.pmed.1002937 51. Mackenzie IS, Hawkey CJ, Ford I, Greenlaw N, Pigazzani F, Rogers A, Struthers AD, Begg AG, Wei L, Avery AJ, Taggar JS, Walker A, Duce SL, Barr RJ, Dumbleton JS, Rooke ED, Townend JN, Ritchie LD, MacDonald TM; ALL-HEART Study Group. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. The Lancet. 2022;400(10359):1195-1205. DOI: 10.1016/S0140-6736(22)01657-9 52. Giannattasio C, Bombelli M, Desideri G, Cicero AFG, Muiesan ML, Rosei EA, Salvetti M, Ungar A, Rivasi G, Pontremoli R, Viazzi F, Facchetti R, Ferri C, Bernardino B, Galletti F, D’Elia L, Palatini P, Casiglia E, Tikhonoff V, Barbagallo CM, Verdecchia P, Masi S, Mallamaci F, Cirillo M, Rattazzi M, Pauletto P, Cirillo P, Gesualdo L, Mazza A, Volpe M, Tocci G, Iaccarino G, Nazzaro P, Lippa L, Parati G, Dell’Oro R, Quarti-Trevano F, Grassi G, Virdis A, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA). Hyperuricemia and risk of cardiovascular outcomes: the experience of the URRAH (Uric Acid Right for Heart Health) project. High Blood Pressure & Cardiovascular Prevention. 2020;27(2):121-128. DOI: 10.1007/s40292-020-00368-z 53. Browne LD, Jaouimaa FZ, Walsh C, Perez-Ruiz F, Richette P, Burke K, Stack AG. Serum uric acid and mortality thresholds among men and women in the Irish health system: a cohort study. European Journal of Internal Medicine. 2021;84:46-55. DOI: 10.1016/j.ejim.2020.10.001 54. Timsans J, Kauppi JE, Kerola AM, Lehto TM, Kautiainen H, Kauppi MJ. Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population. BMJ Open. 2023;13(5):e072110. DOI: 10.1136/bmjopen-2023-072110 55. Johnson RJ, Sanchez Lozada LG, Lanaspa MA, Piani F, Borghi C. Uric acid and chronic kidney disease: still more to do. Kidney International Reports. 2022;8(2):229-239. DOI: 10.1016/j.ekir.2022.11.016    [ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]